Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Show all 18 references

Sorted by citations

Items 501–600 of 999

Disrupting the Approach to Sudden Cardiac Death
Chugh, S. S. (2017) · Circulation · doi:10.1161/circulationaha.117.029932 · Cited by 15
Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz
Laufs, U., Anker, S. D., Falk, V., Pieske, B. M., Baldus, S. E., Perings, C. A., & Birner, C. M. (2017) · Der Kardiologe · doi:10.1007/s12181-017-0143-3 · Cited by 14
Prognostic usefulness of planar 123I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF
Agostini, D., Ananthasubramaniam, K., Chandna, H., Friberg, L., Hudnut, A. G., Koren, M. J., Miyamoto, M. I., Senior, R., Shah, M., Travin, M. I., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01859-w · Cited by 14
Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis
Takenaka, S., Kobayashi, Y., Nagai, T., Kato, Y., Komoriyama, H., Nagano, N., Kamiya, K., Konishi, T., Sato, T., Omote, K., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.04.009 · Cited by 14
Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes
Kiernan, K., Dodge, S. E., Kwaku, K. F., Jackson, L. R., & Zeitler, E. P. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.09.003 · Cited by 13
Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis
Al‐Sadawi, M., Aslam, F., Tao, M., Fan, R., Singh, A., & Rashba, E. J. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.01.001 · Cited by 14
Anesthetic Management of Patients with Dilated Cardiomyopathy Undergoing Noncardiac Surgery
Li, M., & Huang, H. (2023) · Medicina · doi:10.3390/medicina59091567 · Cited by 14
Kommentar zu den ESC-Leitlinien 2015 „Ventrikuläre Arrhythmien und Prävention des plötzlichen Herztodes“
Deneke, T., Borggrefe, M., Hindricks, G., Kirchhof, P. F., Kück, K., Stellbrink, C., & Eckardt, L. (2017) · Der Kardiologe · doi:10.1007/s12181-016-0115-z · Cited by 15
Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice
Bovéda, S., Narayanan, K., Jacob, S., Providencia, R. A., Algalarrondo, V., Bouzeman, A., Beganton, F., Defaye, P., Perier, M., Sadoul, N., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13198 · Cited by 14
Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long‐term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter‐Defibrillator Therapy Delivery) Registry
Pedretti, S., Vargiu, S., Baroni, M., Dellegrottaglie, S., Lanzarin, B., Roghi, A., Milazzo, A., Quattrocchi, G., Lunati, M., & Pedrotti, P. (2018) · Clinical Cardiology · doi:10.1002/clc.22911 · Cited by 14
Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey
Haugaa, K. H., Dan, G., Iliodromitis, K. E., Lenarczyk, R., Marinskis, G., Osca, J., Scherr, D., & Dagres, N. (2018) · EP Europace · doi:10.1093/europace/euy112 · Cited by 14
Polyscore of Non-invasive Cardiac Risk Factors
Steger, A., Müller, A., Barthel, P., Dommasch, M., Huster, K. M., Hnatkova, K., Sinnecker, D., Hapfelmeier, A., Malík, M., & Schmidt, G. P. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00049 · Cited by 14
Effect of Disease-Modifying Agents and Their Association with Mortality in Multi-Morbid Patients with Heart Failure with Reduced Ejection Fraction
Straw, S., McGinlay, M., Relton, S. D., Koshy, A. O., Gierula, J., Paton, M. F., Drozd, M., Lowry, J. E., Cole, C. A., Cubbon, R. M., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12978 · Cited by 13
Use of the wearable cardioverter-defibrillator – the Swiss experience
Kovacs, B., Reek, S., Sticherling, C., Schaer, B. A., Linka, A., Ammann, P., Brenner, R., Krasniqi, N., Müller, A. S., Dzemali, O., et al. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20343 · Cited by 14
Driving following defibrillator implantation: a nationwide register-linked survey study
Bjerre, J., Rosenkranz, S. H., Schou, M., Jøns, C., Philbert, B. T., Larroudé, C. E., Nielsen, J. C., Johansen, J. B., Riahi, S., Melchior, T. M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab253 · Cited by 14
Self-citation
Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
Abumayyaleh, M., Pilsinger, C., El‐Battrawy, I., Kummer, M., Kuschyk, J., Borggrefe, M. M., Mügge, A., Aweimer, A., & Akın, İ. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214989 · Cited by 15
Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy
Higgins, A. Y., Annapureddy, A., Wang, Y., Minges, K. E., Bellumkonda, L., Lampert, R. J., Rosenfeld, L. E., Jacoby, D. L., Curtis, J. P., Miller, E. J., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.12.011 · Cited by 14
Strategies for Sudden Cardiac Death Prevention
Corianò, M., & Tona, F. (2022) · Biomedicines · doi:10.3390/biomedicines10030639 · Cited by 15
Betablockers and Ivabradine Titration According to Exercise Test in LV Only Fusion CRT Pacing
Văcărescu, C., Luca, C. T., Feier, H. B., Gaiță, D. I., Crișan, S., Negru, A. G., Iurciuc, S., Goanță, E.-V., Mornoş, C., Lazăr, M.-A., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051096 · Cited by 14
Inequality between women and men in ICD implantation
Ingelaere, S., Hoffmann, R., Guler, I., Vijgen, J. M., Mairesse, G. H., Blankoff, I., Vandekerckhove, Y. R., de Waroux, J. L. P., Vandenberk, B., & Willems, R. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101075 · Cited by 15
Recent advances in the management of ventricular tachyarrhythmias
Batul, S. A., Olshansky, B., Fisher, J. D., & Gopinathannair, R. (2017) · F1000Research · doi:10.12688/f1000research.11202.1 · Cited by 14
Cardiac resynchronization therapy outcomes in patients with chronic heart failure
Drozd, M., Gierula, J., Lowry, J. E., Paton, M. F., Joy, E., Jamil, H. A., Cubbon, R. M., Kearney, M. T., Cairns, D. A., & Witte, K. K. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000584 · Cited by 14
Myocardial perfusion during atrial fibrillation in patients with non-ischaemic systolic heart failure: a cross-sectional study using Rubidium-82 positron emission tomography/computed tomography
Byrne, C., Hasbak, P., Kjær, A., Thune, J. J., & Køber, L. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey089 · Cited by 14
Self-citation
Risk Stratification in Idiopathic Dilated Cardiomyopathy Patients Using Cardiovascular Coupling Analysis
Rodríguez, J., Schulz, S., Giraldo, B. F., & Voss, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00841 · Cited by 15
Association between Type D personality and outcomes in patients with non-ischemic heart failure
Bundgaard, J. S., Østergaard, L., Gislason, G., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Olesen, L. L., Thøgersen, A. M., Torp-Pedersen, C. T., et al. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02241-6 · Cited by 15
Self-citation
Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis
Crespo, C., Linhart, M., Acosta, J., Soto‐Iglesias, D., Martínez, M., Jáuregui, B., Mira, Á., Restovic, G., Sagarra, J., Auricchio, A., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319873149 · Cited by 14
Sustained Monomorphic Ventricular Tachycardia in Nonischemic Heart Disease
Kanagasundram, A. N., John, R. M., & Stevenson, W. G. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007312 · Cited by 14
Quality of life and the associated risk of all-cause mortality in nonischemic heart failure
Bundgaard, J. S., Thune, J. J., Gislason, G., Fosbøl, E. L., Torp-Pedersen, C. T., Aagaard, D., Nielsen, J. C., Haarbo, J., Thøgersen, A. M., Videbæk, L. M., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.02.008 · Cited by 14
Self-citation
Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence?
Vecchi, A. L., Abete, R., Marazzato, J., Iacovoni, A., Mortara, A., Ponti, R. D., & Senni, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09991-3 · Cited by 14
Reply to: Left Ventricular Midwall Fibrosis as a Predictor of Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy: A Meta-Analysis
Wang, J., Xu, Y., & Chen, Y. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13185 · Cited by 14
Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure
Gasparyan, A. Z., Борисович, Ш. Н., & Skvortsov, A. A. (2020) · Kardiologiia · doi:10.18087/cardio.2020.4.n487 · Cited by 13
The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy
Dauw, J., Martens, P., Nijst, P., Meekers, E. M., Deferm, S., Gruwez, H., Rivero‐Ayerza, M., Herendael, H. V., Pison, L., Nuyens, D., et al. (2022) · EP Europace · doi:10.1093/europace/euac039 · Cited by 13
History and evolution of pacing and devices
Haydock, P., & Camm, A. J. (2022) · Heart · doi:10.1136/heartjnl-2021-320149 · Cited by 14
A novel cardiac magnetic resonance–based personalized risk stratification model in dilated cardiomyopathy: a prospective study
Zhou, D., Zhu, L., Wu, W., Zhuang, B., He, J., Xu, J., Yang, W., Wang, Y., Li, S., Sun, X., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10415-7 · Cited by 13
Implantable cardioverter defibrillators for primary prevention in patients with ischemic and non-ischemic cardiomyopathy: A meta-analysis
Jaiswal, V., Taha, A. M., Joshi, A., Deb, N., Kanagala, S. G., Nebuwa, C. N., Ang, S. P., Halder, A., Rajak, K., Jha, M., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102198 · Cited by 13
Associations Between Biomarkers of Myocardial Injury and Systemic Inflammation and Risk of Incident Ventricular Arrhythmia
Sourour, N., Riveland, E., Naesgaard, P. A., Kjekshus, H., Larsen, A. I., Røsjø, H. R., Omland, T., & Myhre, P. L. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.04.017 · Cited by 13
Anthropometric Measures and Long-Term Mortality in Non-Ischaemic Heart Failure with Reduced Ejection Fraction: Questioning the Obesity Paradox
Butt, J. H., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Gustafsson, F., Kristensen, S. L., Bruun, N. E., Eiskjær, H., Brandes, A., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3424 · Cited by 15
Self-citation
Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age — Insights from the German Device Registry
Köbe, J., Andresen, D., Maier, S., Stellbrink, C., Kleemann, T., Gonska, B., Reif, S., Hochadel, M., Senges, J., & Eckardt, L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.212 · Cited by 13
Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction
Nakamura, H. K., Niwano, S., Fukaya, H., Murakami, M., Kishihara, J., Satoh, A., Yoshizawa, T., Oikawa, J., Ishizue, N., Igarashi, T., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.004 · Cited by 13
Prediction of sudden death in elderly patients with heart failure.
Ayesta, A., Martínez-Sellés, H., de Luna, A. B., & Martínez‐Sellés, M. (2018) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2018.02.008 · Cited by 13
Predicción del riesgo de muerte súbita cardiaca: el papel de la resonancia magnética cardiaca
van der Bijl, P., Podlesnikar, T., Bax, J. J., & Delgado, V. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.04.040 · Cited by 13
Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance
Champ‐Rigot, L., Gay, P., Seita, F., Benouda, L., Morello, R., Pellissier, A., Alexandre, J., Saloux, É., & Milliez, P. (2020) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-020-00640-0 · Cited by 13
Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy
May, B. M., Kochi, A. N., Magalhães, A. P. A., Scolari, F. L., Zimerman, A., Andrades, M. É., Zimerman, L. I., Rohde, L. E. P., & Pimentel, M. (2021) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2021.10.002 · Cited by 13
Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy
Piers, S. R., Androulakis, A. F., Yim, K. S., van Rein, N., Venlet, J., Kapel, G. F., Siebelink, H.-M., Lamb, H. J., Cannegieter, S. C., Man, S.-C., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.009979 · Cited by 13
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
Vijapurapu, R., Bradlow, W. M., Leyva, F., Moon, J., Zegard, A., Lewis, N. T., Kotecha, D., Jovanović, A., Hughes, D. A., Woolfson, P. I., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02133-4 · Cited by 14
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
Tomasoni, D., Adamo, M., Bozkurt, B., Heidenreich, P. A., McDonagh, T. A., Rosano, G. M. C., Virani, S., Zieroth, S. R., & Metra, M. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac124 · Cited by 14
Mechanical dispersion is associated with poor outcome in heart failure with a severely depressed left ventricular function and bundle branch blocks
Stanković, I., Janićijević, A. A., Dimić, A., Stefanovic, M., Vidaković, R., Putniković, B., & Nešković, A. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1387282 · Cited by 13
The Australian and New Zealand Cardiac Implantable Electronic Device Survey: Calendar Year 2017
Mond, H. G., & Crozier, I. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.11.018 · Cited by 13
Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator
Kramer, D. B., Normand, S. T., Volya, R., & Hatfield, L. A. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004763 · Cited by 13
Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy
Raman, K. S., Nucifora, G., Leong, D. P., Marx, C., Shah, R. J., Woodman, R. J., Molaee, P., Shirazi, M. G., McGavigan, A. D., Pasquale, C. G. D., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.018 · Cited by 13
Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure
Packer, M. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.05.013 · Cited by 13
Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis
Liang, Y., Wang, J., Yu, Z., Zhang, M., Pan, L., Nie, Y., Su, Y., & Ge, J. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.018 · Cited by 13
A machine-learning-based method to predict adverse events in patients with dilated cardiomyopathy and severely reduced ejection fractions
Shu, S., Hong, Z., Peng, Q., Zhou, X., Zhang, T., Wang, J., & Zheng, C. (2021) · British Journal of Radiology · doi:10.1259/bjr.20210259 · Cited by 13
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
El‐Battrawy, I., Kovacs, B., Dreher, T. C., Klein, N., Rosenkaimer, S., Röger, S., Kuschyk, J., Saguner, A. M., Kowitz, J., Erath, J. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06007-y · Cited by 13
Dilated cardiomyopathy
Halliday, B. P., Jones, R. E., & Hammersley, D. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00031-0 · Cited by 14
From evidence-based medicine to personalized medicine, with particular emphasis on drug-safety monitoring
Ennezat, P., Cosgrove, S., Bouvaist, H., Maréchaux, S., Guerbaaï, R.-A., Jemtel, T. H. L., Andréjak, M., & Vital-Durand, D. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.01.011 · Cited by 13
Akute und chronische Herzinsuffizienz
Kresoja, K., Schmidt, G., Kherad, B., Krackhardt, F., Spillmann, F., & Tschöpe, C. (2017) · Herz · doi:10.1007/s00059-017-4613-y · Cited by 13
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials
Romero, J. E., Díaz, J. C., Grushko, M. J., Quispe, R., Briceno, D. F., Avendaño, R., Golive, A., Piña, I. L., Natale, A., Garcia, M. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux324 · Cited by 13
Prognosis Analysis of Heart Failure Based on Recurrent Attention Model
Gong, J., Bai, X., Li, D.-A., Zhao, J., & Li, X.-G. (2019) · IRBM · doi:10.1016/j.irbm.2019.08.002 · Cited by 13
Jahresbericht 2017 des Deutschen Herzschrittmacher- und Defibrillator-Registers – Teil 2: Implantierbare Kardioverter-Defibrillatoren (ICD)
Defibrillatoren, B. H. U., & Markewitz, A. (2019) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-019-00648-9 · Cited by 13
The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization
Cleland, J. G. F., Hindricks, G., & Petrie, M. C. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz409 · Cited by 13
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Михайловна, Г. Е., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-3-6-76 · Cited by 12
Comentarios a la guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
de la SEC, G. D. T. D. L. S. P. L. G. E. 2. S. E. D. Y. T. D. L. I. C. A. Y. C. Y. C. D. G. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.012 · Cited by 12
Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy
Theuns, D. A. M. J., Verstraelen, T. E., van der Lingen, A. C. J., Delnoy, P. P. H. M., Allaart, C. P., ERVEN, L. V., Maass, A. H., Vernooy, K., Wilde, A. A. M., Boersma, E. H., et al. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01718-3 · Cited by 12
The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis
Golukhova, E. Z., Bulaeva, N. I., Alexandrova, S. А., Mrikaev, D. V., Gromova, O. I., Рузина, Е. В., & Berdibekov, B. S. (2023) · Clinical Radiology · doi:10.1016/j.crad.2022.12.015 · Cited by 12
Machine learning for prediction of ventricular arrhythmia episodes from intracardiac electrograms of automatic implantable cardioverter-defibrillators
Cha, Y., Attia, I. Z., Metzger, C., López-Jiménez, F. A., Tan, N. Y. L., Cruz, J., Upadhyay, G. A., Mullane, S., Harrell, C., Kinar, Y., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.040 · Cited by 18
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure
Goldenberg, I., Ezekowitz, J. A., Albert, C. M., Alexis, J. D., Anderson, L., Behr, E. R., Daubert, J. P., Palo, K. E. D., Ellenbogen, K. A., Dzikowicz, D. J., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2024.10.078 · Cited by 12
Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment
Zipse, M. M., & Tzou, W. S. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13284 · Cited by 12
Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis
AlTurki, A., Proietti, R., Alturki, H., Essebag, V., & Huynh, T. T. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.12.003 · Cited by 13
Change in indication for cardiac resynchronization therapy?
Lawin, D., & Stellbrink, C. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy488 · Cited by 12
Cambio en la causa de muerte e influencia de la mejora terapéutica con el tiempo en pacientes con insuficiencia cardiaca y fracción de eyección reducida
Fernández-Vázquez, D., Ferrero‐Gregori, A., Garcia, J. A., Otero, I. G., Vázquez, R., Delgado, J. F., Diz, F. W., Bardajı́, A., García‐Pavía, P., Bayés‐Genís, A., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.09.012 · Cited by 12
Malignant Arrhythmogenic Role Associated with RBM20: A Comprehensive Interpretation Focused on a Personalized Approach
Jordà, P., Toro, R., Díez‐López, C., Salazar‐Mendiguchía, J., Fernández-Falgueras, A., Pérez‐Serra, A., Coll, M., Puigmulé, M., Arbelo, E., García‐Álvarez, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020130 · Cited by 12
The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy
Clémenty, N., Bodin, A., Bisson, A., Teixeira‐Gomes, A., Roger, S., Angoulvant, D., Labas, V., & Babuty, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095003 · Cited by 13
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy
Manca, P., NUZZI, V., Cannata, A. N., MERLO, M., & SINAGRA, G. (2021) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05736-7 · Cited by 13
Advances in cardiac resynchronisation therapy: review of indications and delivery options
Keene, D., & Whinnett, Z. I. (2021) · Heart · doi:10.1136/heartjnl-2020-317171 · Cited by 12
Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study
Pelli, A., Junttila, J. M., Kenttä, T. V., Schlögl, S., Zabel, M., Malík, M., Reichlin, T., Willems, R., Vos, M. A., Harden, M., et al. (2021) · EP Europace · doi:10.1093/europace/euab260 · Cited by 12
Self-citation
Does mechanical dyssynchrony in addition to QRS area ensure sustained response to cardiac resynchronization therapy?
Wouters, P. C., van Everdingen, W. M., Vernooy, K., Geelhoed, B., Allaart, C. P., Rienstra, M., Maass, A. H., Vos, M. A., Prinzen, F. W., Meine, M., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab264 · Cited by 12
Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy
Müller‐Leisse, J., Brunn, J., Zormpas, C., Hohmann, S., Hillmann, H. A. K., Eiringhaus, J., Bauersachs, J. K., Veltmann, C., & Duncker, D. (2022) · Sensors · doi:10.3390/s22052037 · Cited by 13
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
Barraud, J., Cautela, J., Orabona, M., Pinto, J., Missenard, O., Laine, M., Thuny, F., Paganelli, F. F., Bonello, L., & Peyrol, M. (2017) · HAL AMU · Cited by 12
Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
Ueda, N., Noda, T., Kusano, K., Yasuda, S., Kurita, T., & Shimizu, W. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.02.004 · Cited by 12
Predictors of serious arrhythmic events in patients with nonischemic heart failure
Pimentel, M., Zimerman, A., Chemello, D., Giaretta, V., Andrades, M. É., Silvello, D., Zimerman, L. I., & Rohde, L. E. P. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0213-7 · Cited by 12
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
Barraud, J., Cautela, J., Orabona, M., Pinto, J., Missenard, O., Laine, M., Thuny, F., Paganelli, F. F., Bonello, L., & Peyrol, M. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i6.531 · Cited by 12
Who Needs an Implantable Cardioverter-Defibrillator? Controversies and Opportunities After DANISH
Petrie, M. C., Connelly, D. T., & Gardner, R. S. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1135 · Cited by 12
Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
Beiert, T., Straesser, S., Malotki, R. J., Stöckigt, F., SCHRICKEL, J. W., & Andrié, R. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.75139 · Cited by 12
Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
Wang, Y., Sharbaugh, M. S., Althouse, A. D., Mulukutla, S. R., & Saba, S. (2018) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2018.08.002 · Cited by 12
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: Clinical phenotyping and outcome correlates
Gentile, P., Paldino, A., Cannata, A. N., Artico, J., Barbati, G., Ramani, F., Fabris, E., Aleksova, A., Stolfo, D., Zecchin, M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.005 · Cited by 12
Left ventricular activation-recovery interval variability predicts spontaneous ventricular tachyarrhythmia in patients with heart failure
Porter, B., Bishop, M. J., Claridge, S., Child, N. M., van Duijvenboden, S., Bostock, J., Sieniewicz, B., Gould, J., Sidhu, B. S., Hanson, B. M., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.11.013 · Cited by 12
Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study
Christensen, A. M., Bjerre, J., Schou, M., Jøns, C., Vinther, M., Gislason, G., Johansen, J. B., Nielsen, J. C., Petersen, H. H., Riahi, S., et al. (2018) · EP Europace · doi:10.1093/europace/euy268 · Cited by 12
Self-citation
Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy—defibrillators
ADELSTEIN, E. C., Althouse, A. D., Davis, L., SCHWARTZMAN, D. S., Bazaz, R. R., Jain, S. K., Wang, N. C., & Saba, S. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13828 · Cited by 12
Arrhythmias in Dilated Cardiomyopathy: Diagnosis and Treatment
Zecchin, M., Muser, D., Serdoz, L. V., Buiatti, A., & Morgera, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-13864-6_10 · Cited by 12
Time-trend treatment effect of cardiac resynchronization therapy with or without defibrillator on mortality: a systematic review and meta-analysis
Veres, B., Fehérvári, P., Engh, M. A., Hegyi, P. J., Gharehdaghi, S., Zima, E., Duray, G. Z., Merkely, B. P., & Kosztin, A. (2023) · EP Europace · doi:10.1093/europace/euad289 · Cited by 12
Decision‐making regarding primary prevention implantable cardioverter‐defibrillators among older adults
Hess, P. L., Matlock, D. D., & Al‐Khatib, S. M. (2019) · Clinical Cardiology · doi:10.1002/clc.23315 · Cited by 12
PRevention of sudden cardiac death aFter myocardial infarction by defibrillator implantation: Design and rationale of the PROFID EHRA randomized clinical trial
Dagres, N., Gale, C. P., Nadarajah, R., Bovéda, S., Merino, J. L., Nielsen, J. C., Kirchhof, P. F., Kutyifa, V., Táborský, M., Thiele, H., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.07.071 · Cited by 11
Self-citation
2025 Clinical practice guidelines for Ventricular arrhythmias of the heart and Sudden cardiac death
Mikhailov, E. N., Gizatulina, T. P., Lebedev, D. S., Golukhova, E. Z., Kharlap, M. S., Лебедева, В. К., Bagnenko, S. F., Artyukhina, Е. А., Babokin, V. E., Batalov, R. E., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6670 · Cited by 14
Miocardio no compactado: ¿una enfermedad o un rasgo fenotípico?
Casas, G., Rodríguez-Palomares, J. F., & González, I. F. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2022.06.009 · Cited by 11
Exploring Health Care Disparities in Genetic Testing and Research for Hereditary Cardiomyopathy: Current State and Future Perspectives
Huang, H., Verma, J., Mok, V., Bharadwaj, H. R., Alrawashdeh, M. M., Aratikatla, A., Sudan, S., Talukder, S., Habaka, M., Tse, G., et al. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1779469 · Cited by 15
Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research
Mistrulli, R., Ferrera, A., Salerno, L., Vannini, F., Guida, L., Corradetti, S., Addeo, L., Valcher, S., Gioia, G. D., Spera, F. R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071602 · Cited by 11
Prognostic value of electroanatomic-guided endomyocardial biopsy in patients with myocarditis, arrhythmogenic cardiomyopathy and non dilated left ventricular cardiomyopathy
Narducci, M. L., Scacciavillani, R., Nano, R. L., Bisignani, A., D’Alessandris, N., Inzani, F. S., Tiziano, F. D., Perna, F., Bencardino, G., Burzotta, F., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132489 · Cited by 11
Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction
Anker, N., Olesen, K. K. W., Thrane, P. G., Gyldenkerne, C., Mortensen, M. B., Nielsen, R. R., Løgstrup, B. B., Würtz, M., Nielsen, J. C., & Mæng, M. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037915 · Cited by 12
Self-citation
Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure
Wallace, N., Wong, K., Desmarais, T., Park, J. J., Krummen, D. E., Lim, W., Campagnari, C., Yagil, A., & Greenberg, B. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.05.061 · Cited by 14

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks